TABLE 2.
Drug | Result at wk 21–29: |
|
---|---|---|
Concn (μM) | Acquired mutations | |
RAL | 0.1 | None |
EVG | 0.05 | A54A/V, E92Q, A265A/G, V277V/M |
DTG | 0.1 | R263K, A54A/V, V277V/M |
Drug | Result at wk 21–29: |
|
---|---|---|
Concn (μM) | Acquired mutations | |
RAL | 0.1 | None |
EVG | 0.05 | A54A/V, E92Q, A265A/G, V277V/M |
DTG | 0.1 | R263K, A54A/V, V277V/M |